Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Cardiac and non-cardiac causes of T-wave inversion in the precordial leads in adult subjects: A Dutch case series and review of the literature.

Said SA, Bloo R, de Nooijer R, Slootweg A.

World J Cardiol. 2015 Feb 26;7(2):86-100. doi: 10.4330/wjc.v7.i2.86.

2.

Influence of perfusate temperature on nasal potential difference.

Bronsveld I, Vermeulen F, Sands D, Leal T, Leonard A, Melotti P, Yaakov Y, de Nooijer R, De Boeck K, Sermet I, Wilschanski M, Middleton PG; European Cystic Fibrosis Society – Diagnostic Network Working Group.

Eur Respir J. 2013 Aug;42(2):389-93. doi: 10.1183/09031936.00097712. Epub 2012 Oct 25.

3.

CFTR biomarkers: time for promotion to surrogate end-point.

De Boeck K, Kent L, Davies J, Derichs N, Amaral M, Rowe SM, Middleton P, de Jonge H, Bronsveld I, Wilschanski M, Melotti P, Danner-Boucher I, Boerner S, Fajac I, Southern K, de Nooijer RA, Bot A, de Rijke Y, de Wachter E, Leal T, Vermeulen F, Hug MJ, Rault G, Nguyen-Khoa T, Barreto C, Proesmans M, Sermet-Gaudelus I; European Cystic Fibrosis Society Clinical Trial Network Standardisation Committee.

Eur Respir J. 2013 Jan;41(1):203-16. doi: 10.1183/09031936.00057512. Epub 2012 Aug 9. Review.

4.

Assessment of CFTR function in homozygous R117H-7T subjects.

de Nooijer RA, Nobel JM, Arets HG, Bot AG, van Berkhout FT, de Rijke YB, de Jonge HR, Bronsveld I.

J Cyst Fibros. 2011 Sep;10(5):326-32. doi: 10.1016/j.jcf.2011.03.009. Epub 2011 Apr 19.

5.

Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis.

de Nooijer R, Bot I, von der Thüsen JH, Leeuwenburgh MA, Overkleeft HS, Kraaijeveld AO, Dorland R, van Santbrink PJ, van Heiningen SH, Westra MM, Kovanen PT, Jukema JW, van der Wall EE, van Berkel TJ, Shi GP, Biessen EA.

Arterioscler Thromb Vasc Biol. 2009 Feb;29(2):188-94. doi: 10.1161/ATVBAHA.108.181578. Epub 2008 Dec 18.

PMID:
19095996
6.

Leucocyte cathepsin K affects atherosclerotic lesion composition and bone mineral density in low-density lipoprotein receptor deficient mice.

Guo J, Bot I, de Nooijer R, Hoffman SJ, Stroup GB, Biessen EA, Benson GM, Groot PH, Van Eck M, Van Berkel TJ.

Cardiovasc Res. 2009 Feb 1;81(2):278-85. doi: 10.1093/cvr/cvn311. Epub 2008 Nov 17.

PMID:
19015136
7.

Vascular endothelial growth factor-A induces plaque expansion in ApoE knock-out mice by promoting de novo leukocyte recruitment.

Lucerna M, Zernecke A, de Nooijer R, de Jager SC, Bot I, van der Lans C, Kholova I, Liehn EA, van Berkel TJ, Yla-Herttuala S, Weber C, Biessen EA.

Blood. 2007 Jan 1;109(1):122-9. Epub 2006 Sep 21.

PMID:
16990600
8.

Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis.

de Nooijer R, Verkleij CJ, von der Thüsen JH, Jukema JW, van der Wall EE, van Berkel TJ, Baker AH, Biessen EA.

Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):340-6. Epub 2005 Nov 23.

PMID:
16306430
9.

Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice.

de Nooijer R, von der Thüsen JH, Verkleij CJ, Kuiper J, Jukema JW, van der Wall EE, van Berkel JC, Biessen EA.

Arterioscler Thromb Vasc Biol. 2004 Dec;24(12):2313-9. Epub 2004 Oct 7.

PMID:
15472128
10.

The acute effects of intravenous nisoldipine on left ventricular function 24 to 72 hours after uncomplicated acute myocardial infarction.

de Nooijer RC, van der Wall EE, Cats VM, van Herpen G, van der Laarse A, Blokland JA, Jaarsma W, Arndt JW, Bruschke AV.

Cardiovasc Drugs Ther. 1988 Dec;2(5):673-8.

PMID:
3154643

Supplemental Content

Loading ...
Support Center